+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Polymerase Chain Reaction (PCR) Market (2018 - 2024)

  • ID: 4721730
  • Report
  • November 2018
  • Region: North America
  • 84 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies
  • BioMérieux
  • Fluidigm Corporation
  • Hoffmann-La Roche Ltd
  • LGC Limited
  • Qiagen NV
  • MORE
The North America Polymerase Chain Reaction Technologies Market is expected to witness market growth of 5.5% CAGR during the forecast period (2018 - 2024). Polymerase chain reaction technology devices are medical devices that are primarily used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are majorly used in different life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics. Additionally, the technology is also used in identifying criminals and child identity in various forensics departments. Further, the device is also being used in diagnosing disease such as middle ear infections, tuberculosis, AIDS, and Lyme diseases. Growing geriatric population, growing prevalence of infectious diseases, rapidly growing diagnostic centers and hospitals, technological advancements, and growing awareness and acceptance of personalized medicine are the factors that drive the polymerase chain reaction technologies market. Nevertheless, growing non-validated home-brew tests and reimbursement issues are the factors that limit the growth of the market. Also, accuracy and timely results for RT-PCR is expected to further add to the challenges to the polymerase chain reaction technologies growth. Less tedious processes open avenues for the PCR market. Additionally, increasing funding towards research and development activities and large untapped markets in developing regions is expected to further add to the market opportunities during the forecast period.

Based on Technology, the market is segmented into Real Time PCR, Digital PCR and Traditional PCR. Based on Application, the market is segmented into Forensics, Research and Clinical. Based on Product, the market is segmented into Instruments, Reagents & consumables, Software and Services. Based on End user, the market is segmented into Biotech & Pharma Company, Diagnostics Centers & Hospitals and Academic & Research Institutions. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • BioMérieux
  • Fluidigm Corporation
  • Hoffmann-La Roche Ltd
  • LGC Limited
  • Qiagen NV
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Polymerase Chain Reaction (PCR) Market, by Technology
1.4.2 North America Polymerase Chain Reaction (PCR) Market, by Application
1.4.3 North America Polymerase Chain Reaction (PCR) Market, by Product
1.4.4 North America Polymerase Chain Reaction (PCR) Market, by End User
1.4.5 North America Polymerase Chain Reaction (PCR) Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Polymerase Chain Reaction Technologies Market by Technology
3.1 Introduction
3.1.1 North America Real-Time PCR Market by Country
3.1.2 North America Digital PCR Market by Country
3.1.3 North America Traditional PCR Market by Country

Chapter 4. North America Polymerase Chain Reaction Technologies Market by Application
4.1.1 North America Polymerase Chain Reaction Technologies in Forensics Market by Country
4.1.2 North America Polymerase Chain Reaction Technologies in Research Market by Country
4.1.3 North America Polymerase Chain Reaction Technologies in Clinical Market by Country

Chapter 5. North America Polymerase Chain Reaction Technologies Market by Product
5.1.1 North America Polymerase Chain Reaction Technologies Instruments Market by Country
5.1.2 North America Polymerase Chain Reaction Technologies Reagents & Consumables Market by Country
5.1.3 North America Polymerase Chain Reaction Technologies Software Market by Country
5.1.4 North America Polymerase Chain Reaction Technologies Services Market by Country

Chapter 6. North America Polymerase Chain Reaction Technologies Market by End User
6.1.1 North America Polymerase Chain Reaction Technologies in Biotech & Pharma Companies Market by Country
6.1.2 North America Polymerase Chain Reaction Technologies in Diagnostic Centers & Hospitals Market by Country
6.1.3 North America Polymerase Chain Reaction Technologies in Academic & Research Institutions Market by Country

Chapter 7. North America Polymerase Chain Reaction Technologies Market by Country
7.1 USA Polymerase Chain Reaction Technologies Market
7.1.1 USA Polymerase Chain Reaction Technologies Market by Technology
7.1.2 USA Polymerase Chain Reaction Technologies Market by Application
7.1.3 USA Polymerase Chain Reaction Technologies Market by Product
7.1.4 USA Polymerase Chain Reaction Technologies Market by End User
7.2 Canada Polymerase Chain Reaction Technologies Market
7.2.1 Canada Polymerase Chain Reaction Technologies Market by Technology
7.2.2 Canada Polymerase Chain Reaction Technologies Market by Application
7.2.3 Canada Polymerase Chain Reaction Technologies Market by Product
7.2.4 Canada Polymerase Chain Reaction Technologies Market by End User
7.3 Mexico Polymerase Chain Reaction Technologies Market
7.3.1 Mexico Polymerase Chain Reaction Technologies Market by Technology
7.3.2 Mexico Polymerase Chain Reaction Technologies Market by Application
7.3.3 Mexico Polymerase Chain Reaction Technologies Market by Product
7.3.4 Mexico Polymerase Chain Reaction Technologies Market by End User
7.4 Rest of North America Polymerase Chain Reaction Technologies Market
7.4.1 Rest of North America Polymerase Chain Reaction Technologies Market by Technology
7.4.2 Rest of North America Polymerase Chain Reaction Technologies Market by Application
7.4.3 Rest of North America Polymerase Chain Reaction Technologies Market by Product
7.4.4 Rest of North America Polymerase Chain Reaction Technologies Market by End User

Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Revenue & Segment analysis
8.1.4 Research and Development
8.2 Bio-Rad Laboratories, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 bioMérieux SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 Takara Bio Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Agilent Technologies
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Fluidigm Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.8 LGC Limited
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expense
8.9 Qiagen NV
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expense
8.1 SYGNIS Pharma AG
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agilent Technologies
  • BioMérieux
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • LGC Limited
  • Qiagen NV
  • SYGNIS Pharma AG
  • Takara Bio, Inc.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll